Posted by on May 7, 2012 at 12:02 pm
May 072012

97. That’s my latest CD4+ count, less than half the count from six weeks ago.

That’s it. I have tried as many alternative treatments as I can think of to reverse the decline. I will be starting my third round of pharmaceutical ARVs as soon as I can get a prescription and fill it.

This decision has been a long time coming, and in hindsight, I probably should have restarted a few months ago. There’s nothing magical about 97, or being below 100, but it’s as good a breaking point as any. I’ve long argued that there are two things to keep in mind about CD4 counts: one is the long-term trend; the other is single- or low double-digit counts.

Peter Staley’s vivid pharma profit dream$

 Posted by on January 27, 2010 at 8:57 am
Jan 272010
Peter Staley's vivid pharma profit dream$

Peter loves all things Pharmaceutical and that is no surprise, considering he apparently lives a pretty good life taking his cut from Pharma profits. As he himself admits, he founded aidsmed.com so he could get off of his low paying disability income. The extent of his sell out is apparent to anyone looking at all the drug ads plastered above his mug on his blog.

Still, his latest post is pretty gauche, even for him. Peter all but begs Gilead, manufacturer of the top selling AIDS drug Atripla, to share some of their ever increasing profits with groups like his. “I certainly hope they’re giving back to affected communities — generously and often,” Peter writes.